Cryo Cell International Inc (CCEL): R&D Expense
$376.3K
Year ended 2025-11-30
$312.0K
Trailing 12 months to 2026-05-31
-0.7%
3-year compound annual growth
+73.6%
5-year compound annual growth
+23.4%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-11-30 | $376.3K | -69.7% | 2026-02-27, From 2024-12-01 |
| 2024-11-30 | $1.24M | +6.1% | 2026-02-27, From 2023-12-01 |
| 2023-11-30 | $1.17M | +204.4% | 2025-02-28, From 2022-12-01 |
| 2022-11-30 | $384.8K | +671.6% | 2024-02-28, From 2021-12-01 |
| 2021-11-30 | $49.9K | +109.1% | 2023-02-28, From 2020-12-01 |
| 2020-11-30 | $23.9K | -20.9% | 2022-02-22, From 2019-12-01 |
| 2019-11-30 | $30.1K | -67.2% | 2021-03-01, From 2018-12-01 |
| 2018-11-30 | $91.8K | +123.1% | 2020-02-28, From 2017-12-01 |
| 2017-11-30 | $41.2K | -22.5% | 2019-02-28, From 2016-12-01 |
| 2016-11-30 | $53.1K | +16.0% | 2018-02-28, From 2015-12-01 |
| 2015-11-30 | $45.8K | -28.9% | 2017-02-28, From 2014-12-01 |
| 2014-11-30 | $64.4K | +78.0% | 2016-02-29, From 2013-12-01 |
| 2013-11-30 | $36.2K | -67.0% | 2015-03-02, From 2012-12-01 |
| 2012-11-30 | $109.6K | -40.4% | 2014-02-28, From 2011-12-01 |
| 2011-11-30 | $184.0K | +38.4% | 2013-02-28, From 2010-12-01 |
| 2010-11-30 | $133.0K | n/a | 2012-02-28, From 2009-12-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $376.3K | -69.7% |
| Marpai, Inc. (MRAI) | 2025-12-31 | $7.0K | -75.9% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $3.02M | -1.7% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $9.50M | n/a |
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $10.09M | +50.5% |
Compare CCEL, MRAI, VMD, PGNY side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗